Abstract

Purpose To compare 3D-CRT, Field-in-Field (FIF) and VMAT for adjuvant radiotherapy of breast cancer. Methods 26 patients (13 with left-sided breast cancer, 13 with right-sided) treated to a prescribed dose of 40 Gy (2.667 Gy/fraction; normalized to the target mean) were considered. For all patients a 3D-CRT and a VMAT plan were simulated. 3D-CRTs were planned with 2 primary tangential fields with physical wedges and 2 additional low weighted segments. VMAT plans were performed with a Rapid Arc (RA) technique using 2 partial arc. In a subgroup of 15 patients FIF technique was implemented, combining two open fields with 2–3 segments in two tangential beam directions, without using wedges. Comparisons were performed in terms of PTV coverage and OARs dose-volume histogram (DVH) parameters, considering optimal/acceptable constraints of RTOG-1005 protocol. The dosimetric value of omolateral (lung/heart) OARs were related to the OARs volume included in the chest concavity and to OAR’s inclusion maximum depth. Results Concerning PTV, coverage was similar for the three techniques. The mean dose to OARs are summarized in the table. RA was sub-optimal for all contralateral OARs because mean doses were significantly (p Conclusions The FIF (3D-CRT) technique is similar to RA for PTV data and presents the best results all contralateral OARs. Only when (omolateral) lung and heart have an inclusion in chest concavity >1.5 cm, RA significantly reduces dose in the high DVH region.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.